Received Oct 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | NA0587 | IM / LA |
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 1 | Z009681 | IM / LA |
Manifestation of local, injection site reaction after administration of both Capvaxive 21 and Comirnaty on anatomical site. Marked erythema, inflammation and pain for a period of 3 or more days since administration
N/A